NASDAQ:SXTC • VGG2161P1650
The current stock price of SXTC is 2.08 USD. Today SXTC is down by -2.35%. In the past month the price decreased by -24.91%. In the past year, price decreased by -99.51%.
ChartMill assigns a technical rating of 0 / 10 to SXTC. When comparing the yearly performance of all stocks, SXTC is a bad performer in the overall market: 99.96% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to SXTC. While SXTC seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months SXTC reported a non-GAAP Earnings per Share(EPS) of -161.76. The EPS decreased by -102.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.66% | ||
| ROE | -43.84% | ||
| Debt/Equity | 0.05 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 28.65 | 951.275B | ||
| JNJ | JOHNSON & JOHNSON | 20.92 | 584.618B | ||
| MRK | MERCK & CO. INC. | 22.63 | 289.542B | ||
| PFE | PFIZER INC | 9.1 | 152.449B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.49 | 123.471B | ||
| ZTS | ZOETIS INC | 17.02 | 51.652B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.9 | 26.443B | ||
| VTRS | VIATRIS INC | 5.61 | 16.373B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.5 | 11.902B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.414B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.72B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 4.704B | ||
| AMRX | AMNEAL PHARMACEUTICALS INC | 13.69 | 4.169B |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
China SXT Pharmaceuticals Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. China SXT Pharmaceuticals Inc is a holding company principally engaged in the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (TCMP). TCMP is a type of Chinese Traditional Medicine (TCM) products. The firm sells three types of TCMP products: Advanced TCMP, Fine TCMP and Regular TCMP. The firm sells its products under the brand Suxuantang. The firm mainly operates its businesses in the domestic market.
IPO: 2019-01-04
CHINA SXT PHARMACEUTICALS IN
178 Taidong Road North
Taizhou JIANGSU 225300 CN
CEO: Feng Zhou
Employees: 75
Phone: 8652386298290
China SXT Pharmaceuticals Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. China SXT Pharmaceuticals Inc is a holding company principally engaged in the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (TCMP). TCMP is a type of Chinese Traditional Medicine (TCM) products. The firm sells three types of TCMP products: Advanced TCMP, Fine TCMP and Regular TCMP. The firm sells its products under the brand Suxuantang. The firm mainly operates its businesses in the domestic market.
The current stock price of SXTC is 2.08 USD. The price decreased by -2.35% in the last trading session.
SXTC does not pay a dividend.
SXTC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.